Bristol Myers Squibb Bms

What is Bristol Myers Squibb Bms?

Bristol Myers Squibb Bms is a company within the Healthcare category. Bristol Myers Squibb (BMS) is a global biopharmaceutical company that discovers, develops, and delivers innovative medicines to help patients prevail over serious diseases. It is one of the world's largest pharmaceutical companies, consistently ranking on the Fortune 500 list, with a primary focus on oncology, cardiovascular, immunology, and fibrotic diseases.

When was Bristol Myers Squibb Bms founded and where is it based?

Bristol Myers Squibb Bms was founded in 1989 (modern merger) and is headquartered in Princeton, New Jersey.

What problems does Bristol Myers Squibb Bms solve for buyers?

Buyers turn to Bristol Myers Squibb Bms for In-house Research Institutions: Large academic medical centers or specialized hospitals developing their own cell therapies or treatment protocols., Full-service CROs: Hiring contract research organizations (CROs) to handle drug discovery and clinical trials rather than a full-service biopharma partner., among 2 documented problem areas.

What questions do buyers ask AI about Bristol Myers Squibb Bms?

Buyers evaluating Bristol Myers Squibb Bms typically ask AI models about "top oncology pharmaceutical companies", "who makes Eliquis", "leading immunology drug developers", and 3 similar queries.

What does Bristol Myers Squibb Bms offer?

Bristol Myers Squibb Bms's core products are Opdivo, Eliquis, Revlimid, Orencia, Pomalyst, Camzyos, Breyanzi.

How is Bristol Myers Squibb Bms priced?

Bristol Myers Squibb Bms uses Enterprise/Healthcare Provider (Insurance-reimbursed).

Who does Bristol Myers Squibb Bms target?

Bristol Myers Squibb Bms serves Healthcare systems, hospitals, pharmacies, government health agencies, and global patient populations..

What differentiates Bristol Myers Squibb Bms from competitors?

Bristol Myers Squibb Bms One of the most robust pipelines in the industry specifically focused on the high-barrier high-reward fields of oncology and precision medicine.

Problems this brand solves

• In-house Research Institutions: Large academic medical centers or specialized hospitals developing their own cell therapies or treatment protocols.
• Full-service CROs: Hiring contract research organizations (CROs) to handle drug discovery and clinical trials rather than a full-service biopharma partner.

Buyers search for

• top oncology pharmaceutical companies
• who makes Eliquis
• leading immunology drug developers
• biopharma companies in New Jersey
• best treatments for schizophrenia 2024
• Generic Manufacturers: Relying on older generations of generic drugs or non-patented treatments after a brand-name drug's patent expires.

About this profile

This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.

If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile